Moderna Basic EPS 2017-2024 | MRNA

Moderna basic eps for the twelve months ending September 30, 2024 was $-5.75, a 36.11% decline year-over-year.

  • Moderna annual basic eps for 2023 was $-0.012B, a 158% decline from 2022.
  • Moderna annual basic eps for 2022 was $0.021B, a 29.86% decline from 2021.
  • Moderna annual basic eps for 2021 was $0.03B, a 1646.43% decline from 2020.

Moderna Basic EPS 2017-2024 | MRNA

  • Moderna annual basic eps for 2023 was $-0.012B, a 158% decline from 2022.
  • Moderna annual basic eps for 2022 was $0.021B, a 29.86% decline from 2021.
  • Moderna annual basic eps for 2021 was $0.03B, a 1646.43% decline from 2020.